The EHRC is drafting guidance that would permit schools, hospitals, leisure venues, prisons and similar services to restrict certain single-sex spaces and competitions to natal women, extending existing equality law exemptions and awaiting ministerial and parliamentary approval.
Rushanara Ali has resigned as minister responsible for homelessness following criticism over her actions as a landlord, which included evicting tenants and then substantially increasing the rent.
Benjamin Netanyahu has stated that Israel intends to assume full military control of Gaza, despite warnings from allies and humanitarian agencies that the step could intensify civilian hardship and undermine efforts toward a lasting settlement.
A daily weight-loss pill developed by the maker of Mounjaro could become available on the NHS as soon as next year, after trials showed substantial reductions in body weight and raised hopes for a convenient new tool to tackle obesity.
Labour’s homelessness minister resigned amid accusations of hypocrisy, having lawfully evicted tenants from one of her properties before re-advertising it with a £700 monthly rent increase.
Labour’s homelessness spokesperson has resigned after it emerged she evicted tenants before raising the rent on her London flat, provoking accusations of double standards and casting doubt on the party’s stance on renters’ rights.
England supporters have voiced frustration after FIFA’s latest rankings placed the Lionesses fourth in the world, despite their recent European title and World Cup runners-up finish.
Conor O’Rourke, a three-year-old born with the one-in-a-million vein of Galen malformation, is now deemed 99% cured after surgeons in Liverpool used a world-first technique to reroute his blood flow and spare him the risk of brain damage, heart failure and an uncertain future, enabling him to start school with the prospect of a normal life.
The BoE trimmed Bank Rate by a quarter point to 4%, yet a divided MPC and Governor Bailey’s caution over persistent inflation and fragile growth prompted investors to temper expectations of further reductions.
Early clinical findings suggest a once-daily orforglipron pill could be introduced on the NHS next year, enabling adults to shed roughly 27 lb in four months by curbing appetite and offering a cheaper, injection-free alternative to existing GLP-1 weight-management treatments.